Accueil / Tag Archives: Research

Tag Archives: Research

Granules India to Add 102 Jobs, Invest $35 Million in Fairfax County Pharmaceutical R&D, Manufacturing Operation

Monday, May 22nd 2017 at 2:30pm UTC Hyderabad-based company expanding presence in Chantilly area FAIRFAX COUNTY, Va.–(BUSINESS WIRE)– Governor Terry McAuliffe today announced that Granules India Ltd., a vertically integrated pharmaceutical company, will invest $35 million into its wholly owned subsidiary, Granules Pharmaceuticals Inc., to expand its pharmaceutical R&D and …

Plus »

GlycoMimetics’ GMI-1271 Receives EU Orphan Drug Designation for Acute Myeloid Leukemia

Thursday, May 25th 2017 at 1:25pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that the European Commission, based on a favorable recommendation from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products, has granted orphan designation for the company’s drug candidate GMI-1271 for the treatment of …

Plus »

Ligand to Participate in Two Upcoming Investor Conferences

Monday, May 22nd 2017 at 1:00pm UTC SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming investor conferences: 14th Annual Craig-Hallum Institutional Investor Conference in Minneapolis. Conference takes place on Wednesday, May 31, 2017 with one-on-one meetings only. John …

Plus »

Octapharma réaffirme son engagement fort envers les patients atteints d’hémophile A avec la publication de nouvelles données cliniques sur la prophylaxie personnalisée avec nuwiq® basée sur l’analyse PK, suivant l’approche NuPreviq

Wednesday, May 24th 2017 at 1:30pm UTC LACHEN, Suisse–(BUSINESS WIRE)– Octapharma annonce de nouvelles données cliniques positives chez 66 patients préalablement traités (PPT) pour hémophilie A sévère (HA) ayant bénéficié d’une prophylaxie personnalisée basée sur une analyse pharmacinetique (PK) avec Nuwiq®, suivant l’approche NuPreviq. Les données de l’étude NuPreviq (GENA-21, …

Plus »

Clinical Ink and endpoint Announce Industry-First Alliance

Tuesday, May 23rd 2017 at 12:00pm UTC eSource and IRT Integration Simplifies the Site Experience SAN FRANCISCO & PHILADELPHIA–(BUSINESS WIRE)– endpoint Clinical, the leading global interactive response technology (IRT®) company, and Clinical Ink, the pioneering provider of eSource and patient engagement technologies, have teamed up to integrate IRT and eSource …

Plus »

Rev Up eCTD Production With Microsystems DocXtools™ at Drug Information Association Annual Meeting

Tuesday, May 23rd 2017 at 12:00pm UTC CHICAGO–(BUSINESS WIRE)– Microsystems, a leading provider of document authoring, editing, formatting and quality control solutions for the life science industry, is launching a new and improved version of DocXtools™ for Life Sciences at the Drug Information Association (DIA) Annual Meeting, June 18–22. DocXtools …

Plus »

Cancer Experts from Sarah Cannon Research Institute Present Latest in Cancer Research at American Society of Clinical Oncology’s 2017 Annual Meeting

Thursday, May 25th 2017 at 10:00am UTC 90+ presentations underscore Sarah Cannon’s expertise in drug development NASHVILLE, Tenn.–(BUSINESS WIRE)– Sarah Cannon announced today that it will present cancer research insights through more than 90 presentations selected by the American Society of Clinical Oncology (ASCO®) at the 2017 Annual Meeting. Hosted …

Plus »

Acurian Announces Hiring of Tom Privette to Lead Global Business Development

Tuesday, May 23rd 2017 at 2:23pm UTC HORSHAM, Pa.–(BUSINESS WIRE)– Acurian Inc., the leading full-service provider of global patient enrollment and retention solutions and a subsidiary of Pharmaceutical Product Development, LLC (PPD), announced today that Tom Privette, Ph.D., has joined the company as vice president and head of global business …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...